The stage is set for lengthy and complex negotiations among the EU institutions on the pharmaceutical reform package after member states expressed very different views on the future structure of the regulatory data protection (RDP) system at the Health Council meeting on 21 June.
Most of the 27 member states support the European Commission’s proposal for a “modulated” system – which includes a cut in baseline RDP – provided it is “clear and predictable” and “respects the need for